Physician profile
Jay Harris Miser
NPI 1053439372
$1,993.95
in general payments reported to CMS, 2019-2025
15 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.77 · 2022: $545 · 2023: $747 · 2024: $458 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,406.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $512.99 | 2022-2025 | Freestyle Libre 3, Proclaim, Eterna |
| Glaxosmithkline, LLC. | $311.01 | 2022-2025 | Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $271.94 | 2022-2024 | Breztri, Andexxa |
| Exact Sciences Corporation | $271.08 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $253.50 | 2021-2024 | Gardasil 9, Pneumovax 23, Vaxneuvance |
| Amgen INC. | $74.27 | 2024-2025 | Evenity, Prolia |
| Pfizer INC. | $54.33 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $50.26 | 2022 | |
| Medtronic, INC. | $49.26 | 2022-2025 | Inceptiv, Intellis Adaptivestim |
| Abbvie INC. | $47.32 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $39.95 | 2022 | |
| Cranial Technologies, INC | $19.92 | 2025 | Doc Band |
| Mannkind Corporation | $15.25 | 2023 | Afrezza |
| Lilly USA, LLC | $13.54 | 2022 | |
| Organon LLC | $9.33 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Miser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.